BSECompany Update1d ago · 17 Nov 2026, 10:22 pm
We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification by the State service of Ukraine on Medicines and Drugs Control.
Senores Pharmaceuticals Ltd · 544319
✦ AI Summary▲ PositiveExpansion
Senores Pharmaceuticals Ltd's subsidiary, Ratnatris Pharmaceuticals Private Limited, has been awarded the PIC/S GMP certification by the State Service of Ukraine on Medicines and Drugs Control, expanding the company's pathway to pursue regulatory approvals in semi-regulated markets.
Analysis Scores
Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment8/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Senores Pharmaceuticals Ltd - 544319 - Regulation 30 Disclosure Regarding Issuance Of Certificate Of GMP Compliance By The State Service Of Ukraine On Medicines And Drugs Control
Attachments (1)
📄pdf
Download →
a75a4949-7ed8-43e7-b414-19002e075eae.pdf
View document text
Date: November 17, 2026
To, To,
Sr. General Manager Sr. General Manager
Listing Department Listing Department
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G
Dalal Street Bandra Kurla Complex
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
BSE Scrip Code: 544319 NSE Symbol: SENORES
Sub.: Regulation 30 Disclosure regarding issuance of Certificate of GMP Compliance by the State
Service of Ukraine on Medicines and Drugs Control
Dear Sir/Madam,
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, we are pleased to announce that the manufacturing facility
of our subsidiary company, Ratnatris Pharmaceuticals Private Limited located at Mehsana, Gujarat has
been awarded with the prestigious Pharmaceutical Inspection Co-operation Scheme (“PIC/S”) Good
Manufacturing Practices (“GMP”) certification by the State Service of Ukraine on Medicines and Drugs
Control (“SMDC”).
With this certification, the Company through it’s subsidiary now has an expanded pathway to pursue
regulatory approvals across semi regulated market.
The certificate of GMP compliance was issued by SMDC on November 16, 2026, which is received by the
Company on November 17, 2026.
You are requested to take the same on record.
Thanking you.
For Senores Pharmaceuticals Limited
Shilpa Sharma
Company Secretary and Compliance Officer
ICSI Membership No.: A34516
Senores Pharmaceuticals Limited
1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park,
Ambali Bopal Road, Ahmedabad-380054, Gujarat, India
P: +91 79 2999 9857 | E: info@senorespharma.com
W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263